This document announces a short course on structure-based drug design for epigenetic targets to be held on June 19, 2013 at the Revere Hotel in Boston prior to a larger conference. The course will review how structural biology has contributed to the discovery of small molecule modulators of epigenetic targets. It will focus on emerging targets such as bromodomains, methyltransferases, and lysine demethylases. Attendees can register online, by phone, or via email.